HANSOH PHARMAC. HD-00001 (3KY) — Tangible Net Worth Ratio
HANSOH PHARMAC. HD-00001 (3KY) has a Tangible Net Worth Ratio of 99.0% as of December 2025. This metric is calculated by deducting intangible assets (€362.65 Million) from net assets (€35.36 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. For live market cap and overall valuation, see 3KY market cap.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
HANSOH PHARMAC. HD-00001 Tangible Net Worth Ratio (2021–2025)
This chart shows how HANSOH PHARMAC. HD-00001's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 99.0%, reflecting net assets of €35.36 Billion with intangible assets of €362.65 Million EUR. Also explore HANSOH PHARMAC. HD-00001 net asset momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for HANSOH PHARMAC. HD-00001 (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for HANSOH PHARMAC. HD-00001 from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See 3KY FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.0% | €35.36 Billion | €362.65 Million | €39.90 Billion | ▼ -0.2 pp |
| 2024 | 99.1% | €28.68 Billion | €245.29 Million | €31.66 Billion | ▼ -0.2 pp |
| 2023 | 99.3% | €25.79 Billion | €177.42 Million | €33.04 Billion | ▼ -0.5 pp |
| 2022 | 99.9% | €22.65 Billion | €33.42 Million | €30.00 Billion | ▼ -0.1 pp |
| 2021 | 99.9% | €20.03 Billion | €17.04 Million | €27.16 Billion | — |